International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Postcoronary case fatality was substantially higher in Asia, Central and Eastern Europe, and South America and Africa compared with Western countries and higher in low- and middle-income countries compared with high-income countries.
Authors
- Jennifer B. Green (ORCID: https://orcid.org/0000-0002-9967-5352)
- Mark Woodward (ORCID: https://orcid.org/0000-0001-9800-5296)
- Rury R. Holman (ORCID: https://orcid.org/0000-0002-1256-874X)
- John Chalmers (ORCID: https://orcid.org/0000-0002-9931-0580)
- Lee-Ling Lim (ORCID: https://orcid.org/0000-0003-3355-8601)
- Amanda Adler (ORCID: https://orcid.org/0000-0002-2797-3385)
- Darren K. McGuire (ORCID: https://orcid.org/0000-0002-6412-7989)
- Philip Clarke (ORCID: https://orcid.org/0000-0002-7555-5348)
- Ruth L. Coleman (ORCID: https://orcid.org/0000-0002-5194-8550)
- Xinyang Hua (ORCID: https://orcid.org/0000-0003-2102-5461)
Institutions
- Parkland Health & Hospital System (US)
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- Duke University (US)
- Chinese University of Hong Kong (HK)
- The George Institute for Global Health (GB)
- John Radcliffe Hospital (GB)
- University of Malaya (MY)
- University of Oxford (GB)
- Clinical Research Institute (US)
- Nuffield Health (GB)
- The George Institute for Global Health (AU)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
- Melbourne Health (AU)
- Imperial College London (GB)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-08-28
- DOI
- https://doi.org/10.2337/dc25-0541
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Merck Sharp and Dohme